Login
Toggle sidebar

Lint: intrahepatic-cholangiocarcinoma-staging

Strong List Colon Position
error

"T1a: solitary tumour ≤5 cm without vascular invasion"

Line 13:1 · When enboldening an intro, the colon should not be bold. '<strong>T1a:</strong> solitary'

"T1b: solitary tumour >5 cm without vascular invasion"

Line 15:1 · When enboldening an intro, the colon should not be bold. '<strong>T1b: </strong>solitary'
Acronyms
warning

"Intrahepatic cholangiocarcinoma staging is conducted most commonly in accordance with the TNM staging classification of the American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC). As of 2018, the staging criteria are in their 8th edition and reflected below 1. The rare mixed hepatocholangiocarcinoma (combined hepatocellular and cholangiocarcinoma) is also staged according to the intrahepatic bile duct classification 2. However, cancers of the perihilar and distal bile ducts are staged differently."

Line 1:114 · 'TNM' has no definition. Spell it out if it's unfamiliar to the audience.

"Intrahepatic cholangiocarcinoma staging is conducted most commonly in accordance with the TNM staging classification of the American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC). As of 2018, the staging criteria are in their 8th edition and reflected below 1. The rare mixed hepatocholangiocarcinoma (combined hepatocellular and cholangiocarcinoma) is also staged according to the intrahepatic bile duct classification 2. However, cancers of the perihilar and distal bile ducts are staged differently."

Line 1:188 · 'AJCC' has no definition. Spell it out if it's unfamiliar to the audience.

"Intrahepatic cholangiocarcinoma staging is conducted most commonly in accordance with the TNM staging classification of the American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC). As of 2018, the staging criteria are in their 8th edition and reflected below 1. The rare mixed hepatocholangiocarcinoma (combined hepatocellular and cholangiocarcinoma) is also staged according to the intrahepatic bile duct classification 2. However, cancers of the perihilar and distal bile ducts are staged differently."

Line 1:234 · 'UICC' has no definition. Spell it out if it's unfamiliar to the audience.

"TX: primary tumour cannot be assessed"

Line 5:9 · 'TX' has no definition. Spell it out if it's unfamiliar to the audience.

"NX: regional lymph nodes cannot be assessed"

Line 32:9 · 'NX' has no definition. Spell it out if it's unfamiliar to the audience.

"The 5-year survival for each stage of intrahepatic cholangiocarcinoma in the AJCC 8th edition is as follows 3:"

Line 76:81 · 'AJCC' has no definition. Spell it out if it's unfamiliar to the audience.
Headings Case
warning

"Primary tumour (T)"

Line 2:5 · 'Primary tumour (T)' should use sentence-style capitalization.

"Regional lymph node (N)"

Line 29:5 · 'Regional lymph node (N)' should use sentence-style capitalization.

"Distant metastases (M)"

Line 38:5 · 'Distant metastases (M)' should use sentence-style capitalization.
Strong
warning

"TX: primary tumour cannot be assessed"

Line 5:1 · Generally, don't use bold in text: '<strong>TX</strong>'

"T0: no evidence of primary tumour"

Line 7:1 · Generally, don't use bold in text: '<strong>T0</strong>'

"Tis: carcinoma in situ (intraductal tumour)"

Line 9:1 · Generally, don't use bold in text: '<strong>Tis</strong>'

"T1: solitary tumour without vascular invasion"

Line 11:1 · Generally, don't use bold in text: '<strong>T1</strong>'

"T1a: solitary tumour ≤5 cm without vascular invasion"

Line 13:1 · Generally, don't use bold in text: '<strong>T1a:</strong>'

"T1b: solitary tumour >5 cm without vascular invasion"

Line 15:1 · Generally, don't use bold in text: '<strong>T1b: </strong>'

"T2:"

Line 19:1 · Generally, don't use bold in text: '<strong>T2</strong>'

"T3: tumour perforating the visceral peritoneum"

Line 25:1 · Generally, don't use bold in text: '<strong>T3</strong>'

"T4: tumour involving local extrahepatic structures by direct invasion"

Line 27:1 · Generally, don't use bold in text: '<strong>T4</strong>'

"NX: regional lymph nodes cannot be assessed"

Line 32:1 · Generally, don't use bold in text: '<strong>NX</strong>'

"N0: no regional lymph node metastasis"

Line 34:1 · Generally, don't use bold in text: '<strong>N0</strong>'

"N1: regional lymph node metastasis present"

Line 36:1 · Generally, don't use bold in text: '<strong>N1</strong>'

"cM0: no evidence of metastases"

Line 41:1 · Generally, don't use bold in text: '<strong>cM0</strong>'

"cM1: distant metastasis"

Line 43:1 · Generally, don't use bold in text: '<strong>cM1</strong>'

"pM1: distant metastasis, microscopically confirmed"

Line 45:1 · Generally, don't use bold in text: '<strong>pM1</strong>'

"stage 0"

Line 50:1 · Generally, don't use bold in text: '<strong>stage 0</strong>'

"Tis, N0, M0"

Line 51:1 · Generally, don't use bold in text: '<strong>​</strong>'

"stage IAT1a, N0, M0"

Line 54:1 · Generally, don't use bold in text: '<strong>stage IA</strong>'

"stage IBT1b, N0, M0"

Line 57:1 · Generally, don't use bold in text: '<strong>stage IB</strong>'

"stage IIT2, N0, M0"

Line 60:1 · Generally, don't use bold in text: '<strong>stage II</strong>'

"stage IIIAT3, N0, M0"

Line 63:1 · Generally, don't use bold in text: '<strong>stage IIIA</strong>'

"stage IIIB"

Line 66:1 · Generally, don't use bold in text: '<strong>stage IIIB</strong>'

"stage IV[Any T], [Any N], M1"

Line 72:1 · Generally, don't use bold in text: '<strong>stage IV</strong>'
List Caps
warning

"Tis: carcinoma in situ (intraductal tumour)"

Line 9:9 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.

"T1a: solitary tumour ≤5 cm without vascular invasion"

Line 13:9 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.

"T1b: solitary tumour >5 cm without vascular invasion"

Line 15:9 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.

"stage IAT1a, N0, M0"

Line 54:34 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.

"stage IBT1b, N0, M0"

Line 57:34 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.
Emphasis
warning

"Tis: carcinoma in situ (intraductal tumour)"

Line 9:33 · Italics should be used only in exceptional circumstances: '<em>in situ</em>'
Headings Valid
warning

Expected headings

  • H1 Terminology
  • H1 Usage
  • H1 Epidemiology
  • H2 Risk factors
  • H2 Associations
  • H1 Clinical presentation
  • H2 Complications
  • H1 Diagnosis
  • H2 Diagnostic criteria
  • H2 Diagnostic clues
  • H1 Pathology
  • H2 Aetiology
  • H2 Location
  • H2 Classification
  • H2 Macroscopic appearance
  • H2 Microscopic appearance
  • H2 Immunophenotype
  • H2 Markers
  • H2 Genetics
  • H1 Radiographic features
  • H2 Plain radiograph
  • H2 Mammography
  • H2 Antenatal ultrasound
  • H2 Transoesophageal echocardiography
  • H2 Ultrasound
  • H2 CT
  • H3 Dual-energy CT
  • H2 Angiography (DSA)
  • H2 MRI
  • H2 CT/MRI
  • H2 Nuclear medicine
  • H3 PET-CT
  • H3 PET-MRI
  • H1 Radiology report
  • H1 Treatment and prognosis
  • H2 Complications
  • H1 History and etymology
  • H1 Differential diagnosis
  • H2 Clinical differential diagnosis
  • H1 Practical points
  • H1 See also

"Primary tumour (T)"

Line 2:1 · "Primary tumour (T)" is not a recognised heading for this article type.

"Regional lymph node (N)"

Line 29:1 · "Regional lymph node (N)" is not a recognised heading for this article type.

"Distant metastases (M)"

Line 38:1 · "Distant metastases (M)" is not a recognised heading for this article type.

"Stage groups"

Line 47:1 · "Stage groups" is not a recognised heading for this article type.

"Prognosis"

Line 75:1 · "Prognosis" is not a recognised heading for this article type.
Oxford Comma
suggestion

"multiple tumours, with or without vascular invasion"

Line 21:14 · Use the Oxford comma in 'tumours, with or without'.